Hoofddorp, The Netherlands, 24 August – Barentz, a leading global specialty ingredients solutions provider, is pleased to announce the appointment of David Wei as Vice President Pharma, Asia Pacific. This strategic appointment reflects Barentz’s continued commitment to strengthening its leadership and accelerating growth across the Asia Pacific region.
David brings more than 25 years of experience in the Pharmaceutical and Nutraceutical industries, with a strong focus on Asia Pacific—including China, Southeast Asia, Australia, New Zealand, and Bangladesh. He has held senior leadership roles that contributed to significant regional growth through strategic market development, team leadership, and strong partnerships with distributors and industry stakeholders. His deep expertise in excipients and delivery systems has been built over decades, including more than 15 years in general management roles and earlier hands-on experience in technical sales across key markets in the region.
David holds a Doctorate in Business Administration from United Business Institute in Belgium and a Master’s degree in Business Administration from Kedge Business School in France.
Anthony Litchfield, Global VP Pharma in Barentz, commented:
“David’s deep understanding of the Asia Pacific’s pharmaceutical landscape, combined with his proven ability to drive commercial growth and build strong partnerships, makes him a valuable addition to our leadership team. We are confident he will play a pivotal role in accelerating our pharma strategy across the region.”
****
ABOUT BARENTZ
Barentz is a global provider of speciality ingredient solutions for the life sciences and performance materials sectors. We form strong partnerships with customers and principals to deliver high-quality ingredients, technical expertise in ingredient selection and application, and tailored services. Established in 1953, Barentz operates in over 70 countries, through our network of laboratories, sourcing, and formulation centres across EMEA, the Americas, and Asia-Pacific. This enables us to serve more than 27,000 customers worldwide, with approximately 2,800 employees and a turnover of approximately €2.3 billion.
Our commitment to responsible business practices has been recognised with a gold rating from EcoVadis®, placing us among the top 2% of companies assessed globally. Guided by our technical expertise, global reach, and commitment to partnership, we remain focused on what matters most: always a better solution. For more information, visit: www.barentz.com.
For more information, please contact:
pressoffice@barentz.com
David Wei, incoming President of Pharma, Asia Pacific